Cell & Gene Therapy Summit China
Join Fortrea at Cell & Gene Therapy Summit China in Shanghai on 29 April from 10:15 till 10:45 to hear Dr Frederick Derosier’s session called Global By Design: Early Decisions That Shape Advanced Therapy Development
Frederick Derosier is a Vice President, Rare Diseases & Advanced Therapies; Therapeutic Strategy Lead for Cell/Gene Therapies in Fortrea with extensive experience guiding global clinical programs across rare diseases and advanced therapies. He aligns scientific strategy, operational execution, and regulatory expectations to enable high quality clinical development, particularly for complex modalities such as cell therapy, gene therapy, and RNA/antisense platforms. Across pharma, biotech, and CRO leadership roles, Dr. Derosier has led first-in-human through late stage and registrational programs, built fit for purpose operating models for advanced therapeutics, and is known for clear, disciplined communication and pragmatic problem solving.
Join us to learn who Fortrea are and how we are striving to be the best CRO partner to innovative Biotech and Pharma companies to drive forward clinical trials with ease. You will hear that advanced cell, gene, and RNA therapies in Asia increasingly require a global first development strategy. This session examines how early scientific, regulatory, manufacturing, and access decisions before first in human studies impact global approval, reimbursement, and long term value. Attendees will gain a practical framework to design portable evidence, scalable supply chains, and globally viable development plans.